Growth signals Headcount growth indicates capacity to take on more projects and potentially scale custom silicone vasculature offerings; target companies with expanding R&D or medical device development programs.

Strategic leadership Appointment of a President and General Manager suggests a focus on market expansion and international reach; engage senior buyers and channel partners to accelerate partnerships and new market entry.

Precision emphasis Use of CT data for clinical precision aligns with demand from medical device developers and training programs seeking accurate anatomical replicas; position as essential vendor for device prototyping and testing.

Cost and testing Silicone vasculature offers a cost-effective alternative to animal cadaver testing; target research labs and simulation centers prioritizing ethical, scalable training tools and regulatory-compliant testing options.

Digital presence Tech stack shows active marketing, e-commerce, and engagement channels; leverage LinkedIn Ads, newsletters, and live chat to generate leads, showcase case studies, and drive direct sales to niche medical education and R&D teams.